Radiation-associated angiosarcoma of the breast: radical resection technique of the entire radiation field

被引:0
|
作者
Thiel, Johannes Tobias [1 ]
Bauer, Michael [1 ]
Daigeler, Adrien
Kavaka, Vladyslav [1 ]
Kolbenschlag, Jonas [1 ]
Steiner, Dominik [1 ]
Storz, Anna [1 ]
Hoffmann, Sebastian [1 ]
机构
[1] Univ Tubingen, BG Trauma Ctr Tubingen, Dept Hand Plast Reconstruct & Burn Surg, Schnarrenbergstr 95, D-72076 Tubingen, Germany
关键词
breast; breast-conserving therapy; chemotherapy; radiation-associated angiosarcoma; surgical technique; MANAGEMENT; CANCER; SURVEILLANCE; SURVIVAL; OUTCOMES; THERAPY; RAAS; RARE;
D O I
10.1177/17588359251317842
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Radiation-associated angiosarcoma of the breast (RAASB) is a rare secondary angiosarcoma that typically develops subsequent to breast-conserving therapy for breast cancer. The parameters of the resection width and depth remain the subject of considerable controversy. More recent data indicate that radical resection of the complete radiation field at the thorax is associated with improved local control and survival.Objectives: The present study investigates the radical resection technique of the entire radiation field and subsequent defect coverage in RAASB, as well as the medium-term follow-up.Design: Monocentric, retrospective, and non-comparative study.Methods: From January 2017 to January 2024 a total of 10 patients with RAASB were treated at our hospital. The radical resection technique was employed in the treatment of all patients, encompassing the entire radiation field. Three patients received local flaps (two of whom received vertical and transversal rectus abdominis muscle flaps and one received a local random pattern flap), while the remaining seven were treated with split-thickness skin grafts for defect coverage.Results: The median age at initial diagnosis of breast cancer was 59.3 +/- 9.41 years, while that of RAASB was 66.2 +/- 8.32 years. The median latency period between the start of irradiation of the chest wall and the initial presentation of RAASB was 6.5 +/- 3.08 years. The cumulative median total radiation dose was 57.23 +/- 8.34 Gray (cumulative Gray) in 9 of the 10 patients. The overall survival (OS) was 80% in the cohort, with a median follow-up period of 40.0 +/- 27.96 months. Three patients exhibited local relapses following radical resection, with two of these patients ultimately succumbing to their condition.Conclusion: Patients with RAASB may benefit from a radical resection of the entire radiation field. Despite the relatively mutilating nature of the procedure, the radical resection technique may have the potential to reduce the rate of local recurrence and prolong OS.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Treatment and Prognosis of Radiation-Associated Breast Angiosarcoma in a Nationwide Population
    Samuli H. Salminen
    Tom Wiklund
    Mika M. Sampo
    Maija Tarkkanen
    Lea Pulliainen
    Tom O. Böhling
    Erkki Tukiainen
    Katja Hukkinen
    Carl P. Blomqvist
    Annals of Surgical Oncology, 2020, 27 : 1002 - 1010
  • [22] Educational Case: Radiation-Associated Angiosarcoma in Patients With Breast Cancer
    Manjee, Kiran
    Sullivan, Megan E.
    ACADEMIC PATHOLOGY, 2020, 7
  • [23] Treatment and Prognosis of Radiation-Associated Breast Angiosarcoma in a Nationwide Population
    Salminen, Samuli H.
    Wiklund, Tom
    Sampo, Mika M.
    Tarkkanen, Maija
    Pulliainen, Lea
    Bohling, Tom O.
    Tukiainen, Erkki
    Hukkinen, Katja
    Blomqvist, Carl P.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (04) : 1002 - 1010
  • [24] Radiation-associated angiosarcoma in the setting of breast cancer mimicking radiation dermatitis: A diagnostic pitfall
    Daniels, Brianne H.
    Ko, Jennifer S.
    Rowe, J. Jordi
    Downs-Kelly, Erinn
    Billings, Steven D.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (05) : 456 - 461
  • [25] Angiosarcoma, Radiation-Associated Angiosarcoma, and Atypical Vascular Lesion
    Lucas, David R.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2009, 133 (11) : 1804 - 1809
  • [26] Surgical management of radiation-associated cutaneous breast angiosarcoma Invited commentary
    Harris, Paul A.
    JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2011, 64 (08): : 1042 - 1042
  • [27] Outcomes for Localized Radiation-Associated Sarcoma (RAS), Excluding Breast Angiosarcoma
    Mitra, D.
    Mito, J.
    Barysauskas, C.
    Raut, C. P.
    Doyle, L.
    Baldini, E. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E755 - E756
  • [28] Radiation-Associated Angiosarcoma of the Breast: The State of the Art of a Rare and Aggressive Disease
    Cozzi, Salvatore
    Ghersi, Sebastiano Finocchi
    Tava, Francesca
    Bardoscia, Lilia
    Najafi, Masoumeh
    Ruggieri, Maria Paola
    Serre, Anne-Agathe
    Roukoz, Camille
    Miguelez, Cristina Gutierrez
    Lazrek, Amina
    Sardaro, Angela
    Taverna, Cecilia
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (08):
  • [29] Radiation-associated breast angiosarcoma: features of diagnostics and treatment (a clinical case)
    Kometova, V.
    Kolyadina, I.
    Hohlova, S.
    Rodionov, V.
    VIRCHOWS ARCHIV, 2021, 479 : S189 - S189
  • [30] Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
    Degnim, Amy C.
    Siontis, Brittany L.
    Ahmed, Safia K.
    Hoskin, Tanya L.
    Hieken, Tina J.
    Jakub, James W.
    Baum, Christian L.
    Day, Courtney
    Schrup, Sarah E.
    Smith, Lauren
    Carter, Jodi M.
    Kho, Tiffany M. Sae
    Glazebrook, Katrina N.
    Vijayasekaran, Aparna
    Okuno, Scott H.
    Petersen, Ivy A.
    CLINICAL CANCER RESEARCH, 2023, 29 (15) : 2885 - 2893